Cargando…
Targeting bladder tumor cells in voided urine of Chinese patients with FITC-CSNRDARRC peptide ligand
OBJECTIVE: To study the practicality of the FITC-CSNRDARRC peptide ligand (containing the Cys–Ser–Asn–Arg–Asp–Ala–Arg–Arg–Cys nonapeptide) in diagnosing and monitoring bladder tumors. MATERIALS AND METHODS: Between March 2011 and September 2011, 80 consecutive patients with radiographic abnormalitie...
Autores principales: | Jia, Xing-You, Yu, Qi, Zhang, Zhe-Hui, Yang, Xiao-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358809/ https://www.ncbi.nlm.nih.gov/pubmed/22623877 http://dx.doi.org/10.2147/OTT.S31368 |
Ejemplares similares
-
Targeted fluorescent imaging of a novel FITC-labeled PSMA ligand in prostate cancer
por: Zhou, Haoxi, et al.
Publicado: (2021) -
Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors
por: Nerli, Rajendra B., et al.
Publicado: (2021) -
FITC labeling of human insulin and transport of FITC-insulin conjugates through MDCK cell monolayer
por: Shah, Darshana, et al.
Publicado: (2019) -
FITC Conjugation Markedly Enhances Hepatic Clearance of N-Formyl Peptides
por: Øie, Cristina Ionica, et al.
Publicado: (2016) -
Diagnosis of bladder cancer from the voided urine specimens using multi-target fluorescence in situ hybridization
por: KE, ZUNFU, et al.
Publicado: (2014)